These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 1519213

  • 1. Effect of leukocyte proteinases on tissue factor pathway inhibitor.
    Petersen LC, Bjørn SE, Nordfang O.
    Thromb Haemost; 1992 May 04; 67(5):537-41. PubMed ID: 1519213
    [Abstract] [Full Text] [Related]

  • 2. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    Gibson TL, Cohen P.
    Growth Horm IGF Res; 1999 Aug 04; 9(4):241-53. PubMed ID: 10512690
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC, Sprecher CA, Foster DC, Blumberg H, Hamamoto T, Kisiel W.
    Biochemistry; 1996 Jan 09; 35(1):266-72. PubMed ID: 8555184
    [Abstract] [Full Text] [Related]

  • 4. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
    Janusz MJ, Doherty NS.
    J Immunol; 1991 Jun 01; 146(11):3922-8. PubMed ID: 2033261
    [Abstract] [Full Text] [Related]

  • 5. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
    Cunningham AC, Hasty KA, Enghild JJ, Mast AE.
    Biochem J; 2002 Oct 15; 367(Pt 2):451-8. PubMed ID: 12117418
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
    Boudier C, Cadène M, Bieth JG.
    Biochemistry; 1999 Jun 29; 38(26):8451-7. PubMed ID: 10387091
    [Abstract] [Full Text] [Related]

  • 7. Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis.
    Anderssen T, Halvorsen H, Bajaj SP, Osterud B.
    Thromb Haemost; 1993 Sep 01; 70(3):414-7. PubMed ID: 8259540
    [Abstract] [Full Text] [Related]

  • 8. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM, Kalafatis M, Tracy PB.
    Biochemistry; 1998 Aug 25; 37(34):11896-906. PubMed ID: 9718313
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.
    Petersen LC, Bjørn SE, Olsen OH, Nordfang O, Norris F, Norris K.
    Eur J Biochem; 1996 Jan 15; 235(1-2):310-6. PubMed ID: 8631347
    [Abstract] [Full Text] [Related]

  • 10. Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity.
    Salemink I, Franssen J, Willems GM, Hemker HC, Li A, Wun TC, Lindhout T.
    Thromb Haemost; 1998 Aug 15; 80(2):273-80. PubMed ID: 9716152
    [Abstract] [Full Text] [Related]

  • 11. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
    Steppich BA, Seitz I, Busch G, Stein A, Ott I.
    Thromb Haemost; 2008 Dec 15; 100(6):1068-75. PubMed ID: 19132232
    [Abstract] [Full Text] [Related]

  • 12. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
    Groutas WC, Chong LS, Venkataraman R.
    Biochem Biophys Res Commun; 1993 Dec 15; 197(2):730-9. PubMed ID: 8267609
    [Abstract] [Full Text] [Related]

  • 13. Synthetic inhibitors of human granulocyte elastase, Part 4. Inhibition of human granulocyte elastase and cathepsin G by non-steroidal anti-inflammatory drugs (NSAID)s.
    Lentini A, Ternai B, Ghosh P.
    Biochem Int; 1987 Dec 15; 15(6):1069-78. PubMed ID: 3440020
    [Abstract] [Full Text] [Related]

  • 14. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
    Burgering MJ, Orbons LP, van der Doelen A, Mulders J, Theunissen HJ, Grootenhuis PD, Bode W, Huber R, Stubbs MT.
    J Mol Biol; 1997 Jun 13; 269(3):395-407. PubMed ID: 9199408
    [Abstract] [Full Text] [Related]

  • 15. Neutrophil elastase potentiates cathepsin G-induced platelet activation.
    Selak MA.
    Thromb Haemost; 1992 Nov 10; 68(5):570-6. PubMed ID: 1333649
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD, Kennedy JA, Zitnik RJ, Kashem MA.
    Biochem Biophys Res Commun; 1999 Jan 27; 254(3):614-7. PubMed ID: 9920787
    [Abstract] [Full Text] [Related]

  • 17. [Various properties of cathepsin G and elastase from swine peripheral blood neutrophils].
    Kraeva LN, Kokriakov VN, Chesnokov IN, Iakovleva MF, Lyzlova SN.
    Biokhimiia; 1988 Apr 27; 53(4):655-62. PubMed ID: 3395645
    [Abstract] [Full Text] [Related]

  • 18. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
    Liu Y, Stack SM, Lakka SS, Khan AJ, Woodley DT, Rao JS, Rao CN.
    Arch Biochem Biophys; 1999 Oct 01; 370(1):112-8. PubMed ID: 10496984
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
    Mitsudo K, Jayakumar A, Henderson Y, Frederick MJ, Kang Y, Wang M, El-Naggar AK, Clayman GL.
    Biochemistry; 2003 Apr 08; 42(13):3874-81. PubMed ID: 12667078
    [Abstract] [Full Text] [Related]

  • 20. Ultrastructural changes of the skin induced by human leukocyte elastase and cathepsin G.
    Glinski W, Kuligowski M, Pierozynska-Dubowska M, Glinska-Ferenz M, Jablonska S.
    Acta Derm Venereol; 1991 Apr 08; 71(4):277-82. PubMed ID: 1681641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.